DEBORAH B. HORN
Deborah Bade Horn DO, MPH, MFOMA is an obesity medicine specialist, global speaker,
physician scientist, educator, and advocate for obesity. She is the Medical Director at the UT
Center for Obesity Medicine and Metabolic Performance, Associate Professor in the at the
University of Texas McGovern Medical School in Houston, and program Director for the Allison
Family Foundation Fellowship in Clinical Obesity Medicine and Metabolism. She is a founding
member of the Obesity Medicine Fellowship Council and sits on the Clinical Care Committee for
the World Obesity Federation and the Clinical Science Section for the Obesity Society. She is a
Master Fellow and a Past-President of the Obesity Medicine Association.
physician scientist, educator, and advocate for obesity. She is the Medical Director at the UT
Center for Obesity Medicine and Metabolic Performance, Associate Professor in the at the
University of Texas McGovern Medical School in Houston, and program Director for the Allison
Family Foundation Fellowship in Clinical Obesity Medicine and Metabolism. She is a founding
member of the Obesity Medicine Fellowship Council and sits on the Clinical Care Committee for
the World Obesity Federation and the Clinical Science Section for the Obesity Society. She is a
Master Fellow and a Past-President of the Obesity Medicine Association.
Check the activity agenda
Thursday, June 27, 2024
• Room 1 - Alfredo Halpern
14:00-15:30
SESSION: HETEROGENEITY IN RESPONSES TO OBESITY TREATMENT
Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella
Predictors of weight loss in incretin-based therapies
What have we learned about the role of genetics in predicting response to obesity interventions?
Energy compensation, metabolic adaptation and physical activity
Discussion
Coordinator: Bruno Geloneze (SP)
Coordinator: Silvana Pannain (United States)
Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella
Predictors of weight loss in incretin-based therapies
Speaker: Deborah B. Horn (United States)
What have we learned about the role of genetics in predicting response to obesity interventions?
Speaker: Fernando Gerchman (RS)
Energy compensation, metabolic adaptation and physical activity
Speaker: Kevin D. Hall (United States)
Discussion
• Room 4 - Peter Kopelman
16:30-17:30
MEET THE EXPERT: SWITCHING DRUGS IN OBESITY TREATMENT: IN WHOM, WHEN AND HOW?
Speaker: Deborah B. Horn (United States)
Friday, June 28, 2024
• Room 1 - Alfredo Halpern
16:30-18:00
SESSION: THE CHALLENGE OF WEIGHT MAINTENANCE
Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima
Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery
How to reduce barriers for the long term pharmacological treatment of obesity?
What do we know about successful weight maintainers?
Discussion
Coordinator: Deborah B. Horn (United States)
Coordinator: Paul Camperos (Venezuela, RB)
Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima
Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery
Speaker: Kevin D. Hall (United States)
How to reduce barriers for the long term pharmacological treatment of obesity?
Speaker: Nicholas Finer (United Kingdom)
What do we know about successful weight maintainers?
Speaker: Cintia Cercato (SP)
Discussion
Saturday, June 29, 2024
• Room 2 - John Waterlow
08:00-09:30
SESSION: BODY COMPOSITION AND MUSCLE MASS: BEYOND THE OBVIOUS
Abstracts - 129740: THE THERAPEUTIC POTENTIAL OF MICRORNA-22 IN MASH AND OBESITY - Presenter: Riccardo Panella
Impact of sleep deprivation and disruption on body composition during weight loss treatments
Effect of alcohol intake on BW and BC
Body composition with Anti obesity medication
Discussion
Coordinator: Cynthia Melissa Valerio (RJ)
Abstracts - 129740: THE THERAPEUTIC POTENTIAL OF MICRORNA-22 IN MASH AND OBESITY - Presenter: Riccardo Panella
Impact of sleep deprivation and disruption on body composition during weight loss treatments
Speaker: Rafael Genario (SP)
Effect of alcohol intake on BW and BC
Speaker: Erika Bezerra Parente (Germany)
Body composition with Anti obesity medication
Speaker: Deborah B. Horn (United States)
Discussion
Venue
Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
website ACCOMMODATION
PROMOTED BY
MANAGEMENT
Tourism Agency
DIAMOND SPONSOR
GOLD SPONSOR
BRONZE SPONSOR
SPONSOR
